Stocktoria

TELEFLEX INC TFX

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1980-03-17 · LEI

TELEFLEX INC (TFX) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.05% (safety: safe). FY2025 revenue was $2.0B at a -45.4% net margin.

Chart by TradingView
58/100
Stocktoria Quality Score · grade B
5/9
Piotroski F — financial health
3.56
Altman Z″ — distress risk · safe
0.7%
Dividend yield 5y avg · safe · Dividend payout -6.7%
-2.81
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
8 5 6 7 4 7 5 5 7 5 2016201720182019202020212022202320242025
Altman Z″
4.95 2.98 3.00 3.63 3.54 4.26 4.52 4.22 4.34 3.56 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$136.32 as of 2026-08-01 · +7.8% 1y
$104.37$136.7152-wk

Beneish M-score: -2.81 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$5.7B
Dividend yield 5y avg0.7%
Net margin 5y avg2%
Return on equity 5y avg0.5%
Beta0.82
Employees15,500

Analyst price target

$145.89 +7% vs last
· 9 analysts
target range $135.00 – $160.00 · median $145.00
4 strong buy · 7 hold
Recent analyst actions
DateFirmRating
2026-06-08Piper SandlerOverweight (up)
2026-05-11Truist SecuritiesHold (reit)
2026-05-08RBC CapitalOutperform (up)
2026-05-08Wells FargoEqual-Weight (main)
2026-03-27Raymond JamesOutperform (up)
2026-02-27RBC CapitalSector Perform (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 63%
Net marginstronger than 28%
Return on equitystronger than 38%
Revenue growthstronger than 76%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.169
Retained earnings / assets0.453
EBIT / assets0.017
Equity / liabilities0.817

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
TFXTELEFLEX INC5/93.56+17.2%
ICUIICU MEDICAL INC/DE6/92.9-6.3%
IARTINTEGRA LIFESCIENCES HOLDINGS CORP5/91.17+1.5%
MMSIMERIT MEDICAL SYSTEMS INC7/94.9333.3+11.8%
PENPenumbra Inc6/98.5970.1+17.5%
HAEHAEMONETICS CORP7/92.8536.1-2%
PODDINSULET CORP6/94.7844.4+30.7%

All Manufacturing companies →

About TELEFLEX INC

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

FAQ

Is TFX financially healthy?

TELEFLEX INC's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does TFX pay a dividend, and is it safe?

Yes. TELEFLEX INC pays a dividend yielding about 1.05% with a -6.7% payout ratio, rated “safe” for safety.

How profitable is TFX?

In FY2025, TELEFLEX INC had a net margin of -45.4% and a return on equity of -29.0%.

Is TFX overvalued or undervalued?

TELEFLEX INC trades at about 92.1× trailing earnings — above its 10-year norm (10-year range 26.6×–121.8×, median 37.9×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for TFX?

The average Wall-Street price target for TELEFLEX INC is $145.89, about 7.0% above the recent price, from 9 analysts.

Is TFX a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on TELEFLEX INC: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a dividend yield of 1.05%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.